Recipient of federal assistance · BETHESDA, MD

IMMUNOBLUE, LLC

IMMUNOBLUE, LLC received $1.1M in federal grants and other assistance in FY2026, on 2 actions, −2.5% vs FY2025. It has no federal contracts in the loaded years. Since FY2024: $2.6M. Its largest awarding agency was National Institutes of Health ($1.1M).

Assistance · FY2026
$1.1M
New awards
0
Actions
2
Since FY2024
$2.6M
UEI
ZGGMBZWMF5H3
Location
BETHESDA, MD
Businesses
Open in the explorerFederal grants & assistance

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

Assistance by fiscal year

  1. 399.7KFY2024
  2. 1.1MFY2025
  3. 1.1MFY2026

By type

  1. Grants$1.1M100%

Top programs · Awarding agencies

Obligations in FY2026.

Top programs

  1. 93.395 · Cancer Treatment Research$1.1M100%

Awarding agencies

  1. National Institutes of Health$1.1M100%
    Department of Health and Human Services

Largest awards

  1. ENGINEERED GLIOBLASTOMA-SPECIFIC T CELLS USING IMMUNOSTIMULATORY PHOTOTHERMAL NANOPARTICLES - PROJECT SUMMARY THE GOAL OF THIS STTR PHASE…$2.2M
    93.395 · Cancer Treatment Research· National Institutes of Health· Project grant· Sep 11, 2025 – Aug 18, 2026· R42CA287488
  2. ENGINEERED GLIOBLASTOMA-SPECIFIC T CELLS USING IMMUNOSTIMULATORY PHOTOTHERMAL NANOPARTICLES - PROJECT SUMMARY THE GOAL OF THIS STTR PHASE I…$399.7K
    93.395 · Cancer Treatment Research· National Institutes of Health· Project grant· Sep 3, 2024 – Mar 26, 2026· R41CA287488

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 7, 2026, loaded Oct 7, 2026 · FY2024–FY2026.